Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
about
The Role of cccDNA in HBV Maintenance.Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway.Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro.Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.
P2860
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
@ast
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
@en
type
label
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
@ast
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
@en
prefLabel
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
@ast
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
@en
P2093
P2860
P356
P1476
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine
@en
P2093
Cyril Llamoso
Kwang-Hyub Han
Robert A de Man
Scott Bowden
Stephen Locarnini
Ting-Tsung Chang
You-Chen Chao
P2860
P304
P356
10.3748/WJG.V21.I15.4644
P407
P50
P577
2015-04-01T00:00:00Z